While Washington state’s biotech industry is on the up and up, it still lags far behind hubs like San Francisco and Cambridge, Mass.
Washington’s biotech industry is not only lagging behind, it is actually regressing, said Hans Bishop, CEO of Seattle-based Juno Therapeutics, a biotech company focused on developing cancer immunotherapies.
Speaking at the GeekWire Summit 2016, Bishop said that if the area wants to catch up, the key is encouraging more biotech companies to open up shop in the state.
